Literature DB >> 31792678

Prevention and Treatment of Atherosclerosis: The Use of Nutraceuticals and Functional Foods.

Francesco Visioli1,2, Andrea Poli3.   

Abstract

Nutritional interventions are effective and - in theory - easy to implement primary and secondary prevention strategies that reduce several risk factors of atherosclerosis and cardiovascular disease (CVD). Yet, because of (a) the severe impact of CVD in terms of mortality, morbidity, quality of life, and economy, (b) the proved role of LDL plasma concentrations as the most critical risk factor, and (c) the obstacles found both in terms of biological effects and compliance of the patient by an exclusively dietary intervention, food supplements or nutraceuticals are now valuable resources for physicians. As regards cholesterol control, several preparations are available in the market, and we will critically review them in this chapter.
© 2019. The Author(s).

Entities:  

Keywords:  Atherosclerosis; Cardiovascular disease; Cholesterol; Diet; Functional foods; Nutraceuticals

Mesh:

Year:  2022        PMID: 31792678     DOI: 10.1007/164_2019_341

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  56 in total

1.  Management of Blood Cholesterol.

Authors:  Francis J Alenghat; Andrew M Davis
Journal:  JAMA       Date:  2019-02-26       Impact factor: 56.272

Review 2.  Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Nutr Rev       Date:  2017-09-01       Impact factor: 7.110

Review 3.  Metabolic effects of plant sterols and stanols (Review).

Authors:  Ariënne de Jong; Jogchum Plat; Ronald P Mensink
Journal:  J Nutr Biochem       Date:  2003-07       Impact factor: 6.048

Review 4.  Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.

Authors:  Harry R Davis; Scott W Altmann
Journal:  Biochim Biophys Acta       Date:  2009-01-19

5.  Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products.

Authors:  Chia-Hao Chen; Jyh-Chin Yang; Yow-Shieng Uang; Chun-Jung Lin
Journal:  Int J Pharm       Date:  2013-01-23       Impact factor: 5.875

Review 6.  Role of dietary beta-glucans in the prevention of the metabolic syndrome.

Authors:  Lieselotte Cloetens; Matilda Ulmius; Anna Johansson-Persson; Björn Akesson; Gunilla Onning
Journal:  Nutr Rev       Date:  2012-08       Impact factor: 7.110

Review 7.  Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?

Authors:  Marinaldo Pacífico Cavalcanti Neto; Jailane de Souza Aquino; Larissa de Fátima Romão da Silva; Ruanniere de Oliveira Silva; Keyth Sulamitta de Lima Guimarães; Yohanna de Oliveira; Evandro Leite de Souza; Marciane Magnani; Hubert Vidal; José Luiz de Brito Alves
Journal:  Pharmacol Res       Date:  2018-02-14       Impact factor: 7.658

8.  Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.

Authors:  David J Becker; Ram Y Gordon; Steven C Halbert; Benjamin French; Patti B Morris; Daniel J Rader
Journal:  Ann Intern Med       Date:  2009-06-16       Impact factor: 25.391

9.  Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.

Authors:  Arrigo F G Cicero; Lucio C Rovati; Ivo Setnikar
Journal:  Arzneimittelforschung       Date:  2007

10.  Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.

Authors:  Yong Cai; Guoqiang Xing; Tian Shen; Shuxian Zhang; Jianyu Rao; Rong Shi
Journal:  Lipids Health Dis       Date:  2017-12-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.